Antibody response to measles immunization at seven months old in rural Ghanaian infants

Simple item page
dc.contributor.authorSakatoku, H.
dc.contributor.authorNakano, T.
dc.contributor.authorAfari, E.A.
dc.date.accessioned2019-11-01T12:42:08Z
dc.date.available2019-11-01T12:42:08Z
dc.date.issued1990-03
dc.descriptionJournal Article on antibody response to measles immunizationen_US
dc.description.abstractA serological study was carried out in three rural communities in southern Ghana in order to determine the optimal age for measles immunization. The live hyperattenuated measles vaccine (Schwarz strain) was inoculated subcutaneously; into infants aged three to eleven months. The maternal measles antibodies in the infants started decreasing after 7 months, while the seroconversion rate after the immunization was increasing after 6 months. Forty seven infants were given the measles vaccines at the age of 7 months. The seroconversion rate was 91.5%. There were no side effects. These results indicate that measles immunization can be administered effectively at the age of 7 months.en_US
dc.identifier.urihttp://www.ghanamedj.org/archives/GMJ%201990%20Vol%2024%20No%201/Antibody%20response%20to%20measles%20immunization.pdf
dc.identifier.urihttp://ugspace.ug.edu.gh/handle/123456789/33299
dc.language.isoenen_US
dc.publisherGhana Medical Journalen_US
dc.relation.ispartofseries24;1
dc.subjectmeasles immunizationen_US
dc.subjecthyperattenuated measlesen_US
dc.subjectAntibodyen_US
dc.subjectrural Ghanaian infantsen_US
dc.titleAntibody response to measles immunization at seven months old in rural Ghanaian infantsen_US
dc.typeArticleen_US

Files

License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Department of Epidemiology and Disease Control